Unjha Formulations (BOM:531762) ROCE %: -51.08% (As of Mar. 2026)


BOM:531762 Unjha Formulations Ltd BOM:531762
79 GF Score
Price ₹19.50
GF Value ₹23.07
Valuation Modestly Undervalued
View Full Analysis

What is Unjha Formulations ROCE %?

Unjha Formulations BOM:531762 +5.12% 79 ROCE % is -51.08% as of Mar. 2026. GuruFocus rates BOM:531762 with a GF Score™ of 79/100 and a GF Value™ of ₹23.07 (Modestly Undervalued).

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Unjha Formulations's annualized ROCE % for the quarter that ended in Mar. 2026 was -51.08%.

Unjha Formulations  (BOM:531762) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Unjha Formulations ROCE % Related Terms

Unjha Formulations ROCE % Historical Data

* Premium members only.

The historical data trend for Unjha Formulations's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unjha Formulations ROCE % Chart

Unjha Formulations Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.76 15.32 19.39 18.08 27.53

Unjha Formulations Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -37.05 49.84 75.39 22.21 -51.08
BOM:531762
79GF Score
Unjha Formulations Ltd BOM:531762
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Unjha Formulations ROCE % Calculation

Unjha Formulations's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=9.617/( ( (45.565 - 14.129) + (55.104 - 16.67) )/ 2 )
=9.617/( (31.436+38.434)/ 2 )
=9.617/34.935
=27.53 %

Unjha Formulations's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-19.632/( ( (0 - 0) + (55.104 - 16.67) )/ 1 )
=-19.632/( ( 0 + 38.434 )/ 1 )
=-19.632/38.434
=-51.08 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -51.08% mean?
Unjha Formulations (BOM:531762) has a ROCE % of -51.08% as of Mar. 2026.
Is Unjha Formulations' ROCE % too high?
Unjha Formulations' current ROCE % is -51.08%. Overall, Unjha Formulations has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Unjha Formulations' ROCE % compare to ZTS and UTHR?
Unjha Formulations' ROCE % of -51.08% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Unjha Formulations's current ROCE % is -51.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unjha Formulations stock overvalued right now?
Based on GuruFocus' analysis, Unjha Formulations (BOM:531762) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹23.07, compared to a current price of ₹19.50 — trading 15.5% below its estimated fair value. The current ROCE % is -51.08%. Unjha Formulations' overall GF Score™ is 79/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Unjha Formulations (BOM:531762), the current ROCE % is -51.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Unjha Formulations (BOM:531762) Overvalued in 2026?

Based on GuruFocus' analysis, Unjha Formulations stock appears to be undervalued. The current stock price of ₹19.50 is trading 15.5% below its estimated GF Value™ of ₹23.07. GuruFocus considers Unjha Formulations to be Modestly Undervalued.

Key valuation signals for BOM:531762:

  • ROCE %: -51.08%
  • GF Value™: ₹23.07 vs. price of ₹19.50 (15.5% below fair value)
  • GF Score™: 79/100

No single metric tells the full story. See the BOM:531762 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Unjha Formulations Business Description

Address Khali Char Rasta, State Highway, Sidhpur, Khali, Patan, GJ, IND, 384151
Unjha Formulations Ltd is an India-based manufacturer and exporter of Ayurvedic products. The company products include Isabgol powder under the Fibron and Fibron SF name, and Sat-Isabgol and Isabgol Husk. It also offers human and veterinary medicines.
79GF Score

Get the complete analysis for BOM:531762

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹19.50
Price
₹23.07
GF Value